Gotto G, Drachenberg DE, Chin J, Casey R, Fradet V, Sabbagh R, et al. Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC. CUAJ [Internet]. 2020 Jun. 16 [cited 2026 Apr. 29];14(12):E616-20. Available from: https://cuaj.ca/index.php/journal/article/view/6388